Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
FINRA Charges Oppenheimer $921K For Overcharging Customers December 13, 2013 Irvin Jackson Add Your CommentsFinancial industry regulators hit Oppenheimer & Co. with an order to pay more than $921,000 in fines and restitution for overcharging customers and for failing to adequately supervise employees.The charge was handed down by the Financial Industry Regulatory Authority (FINRA) on December 9, ordering Oppenheimer to pay $675,000 for charging unfair prices in municipal securities transactions and for providing inadequate supervision. The company was also ordered to pay more than $246,000 in restitution, plus interest, to customers that it overcharged, according to a FINRA press release.At issue were 89 customer transactions that were marked up by the company’s head municipal securities trader, David Sirianni. According to FINRA, from July 1, 2008 through June 30, 2009, he marked up transactions from 5.01% to 15.57% above the actual cost. Most of the transactions were increased more than 9.4% in cost.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONFINRA indicates that Sirianni bought municipal securities on Oppenheimer’s behalf, held them overnight and then resold them at unfair prices. He has been personally fined $100,000 and suspended for 60 days.Oppenheimer should have detected the price irregularities and stopped them, FINRA determined. However, the company’s supervisory system only looked at one report on intra-day transactions to make sure the pricing was fair. If one of the company’s traders bought municipal securities and held them for a day or longer, the company did not review the pricing.“FINRA has no tolerance for firms or individuals who charge customers excessive markups,” wrote Thomas Gira, FINRA’s executive vice president and head of market regulation. “Oppenheimer charged customers unfair prices in numerous municipal securities transactions and failed to properly supervise municipal securities transactions with its customers.”FINRA oversees all securities firms doing business in the United States, providing arbitration services for claims against stock brokers and serving to protect investors by making sure the securities industry operates fairly and honestly.The authority was created in July 2007 as a successor to the National Association of Securities Dealers, to arbitrateย stock broker fraud claimsย that can include charges of breach of contract, breach of fiduciary duty, negligence, misrepresentation, unauthorized trading and other claims that investments were improperly handled. Written by: Irvin JacksonSenior Legal Journalist & Contributing EditorIrvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Financial Abuse, Financial Fraud, FINRA, OppenheimerMore Lawsuit Stories Hearing on Abbott, Nevro SCS Lawsuit MDL Centralization Set for September 2026 August 26, 2026 Meta Reaches $17 Billion Instagram and Facebook Addiction Lawsuit Settlement With 29 States August 26, 2026 Athena Bitcoin Class Action Lawsuit Says Fraud Safeguards Failed to Protect Scam Victims August 26, 2026 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Hearing on Abbott, Nevro SCS Lawsuit MDL Centralization Set for September 2026 (Posted: today)The JPML will hear oral arguments in late September over whether to consolidate all federal Abbott Laboratories and Nevro spinal cord stimulator lawsuits for coordinated pretrial proceedings.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITJudge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (08/24/2026)Boston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks (08/18/2026)Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer (08/14/2026) Lawsuit Alleges DraftKings Predictions ‘Event Contracts’ Are Unlicensed Sports Betting (Posted: yesterday)A California man has filed a class action lawsuit alleging DraftKings offers sports betting through its Predictions platform in states where it lacks sportsbook authorization.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITFanDuel Addiction Lawsuit Alleges Targeted Advertising Caused Substantial Gambling Losses (08/19/2026)DraftKings Predictions Lawsuit Seeks Refunds for Illegal Sports Betting Losses (08/11/2026)Class Action Lawsuit Claims DraftKings Is Dodging State Gambling Laws (07/31/2026) Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 5 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026)
Meta Reaches $17 Billion Instagram and Facebook Addiction Lawsuit Settlement With 29 States August 26, 2026
Athena Bitcoin Class Action Lawsuit Says Fraud Safeguards Failed to Protect Scam Victims August 26, 2026
Hearing on Abbott, Nevro SCS Lawsuit MDL Centralization Set for September 2026 (Posted: today)The JPML will hear oral arguments in late September over whether to consolidate all federal Abbott Laboratories and Nevro spinal cord stimulator lawsuits for coordinated pretrial proceedings.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITJudge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (08/24/2026)Boston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks (08/18/2026)Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer (08/14/2026)
Lawsuit Alleges DraftKings Predictions ‘Event Contracts’ Are Unlicensed Sports Betting (Posted: yesterday)A California man has filed a class action lawsuit alleging DraftKings offers sports betting through its Predictions platform in states where it lacks sportsbook authorization.MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITFanDuel Addiction Lawsuit Alleges Targeted Advertising Caused Substantial Gambling Losses (08/19/2026)DraftKings Predictions Lawsuit Seeks Refunds for Illegal Sports Betting Losses (08/11/2026)Class Action Lawsuit Claims DraftKings Is Dodging State Gambling Laws (07/31/2026)
Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 5 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026)